HSBC Holdings’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

HSBC Holdings’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-56,900	Closed	-$1.78M	–	3216
2025 Q4	$1.78M	Buy	56,900 +16,000	+39%	+$394K	﹤0.01%	1621
2025 Q3	$826K	Buy	40,900 +9,200	+29%	+$162K	﹤0.01%	1876
2025 Q2	$533K	Sell	31,700 -9,200	-22%	-$148K	﹤0.01%	2121
2025 Q1	$630K	Buy	+40,900	New	+$731K	﹤0.01%	1966
2022 Q1	–	Sell	-50,100	Closed	-$401K	–	3479
2021 Q4	$401K	Hold	50,100	–	–	﹤0.01%	2598
2021 Q3	$488K	Sell	50,100 -3,000	-6%	-$28.1K	﹤0.01%	2260
2021 Q2	$526K	Sell	53,100 -27,000	-34%	-$286K	﹤0.01%	2133
2021 Q1	$924K	Sell	80,100 -50,500	-39%	-$579K	﹤0.01%	1647
2020 Q4	$1.25M	Buy	130,600 +79,500	+156%	+$762K	﹤0.01%	1565
2020 Q3	$460K	Buy	+51,100	New	+$541K	﹤0.01%	1995
2020 Q2	–	Sell	-29,000	Closed	-$260K	–	2852
2020 Q1	$260K	Hold	29,000	–	–	﹤0.01%	2138
2019 Q4	$289K	Hold	29,000	–	–	﹤0.01%	2577
2019 Q3	$200K	Hold	29,000	–	–	﹤0.01%	2870
2019 Q2	$268K	Hold	29,000	–	–	﹤0.01%	2385
2019 Q1	$455K	Hold	29,000	–	–	﹤0.01%	2152
2018 Q4	$447K	Hold	29,000	–	–	﹤0.01%	2151
2018 Q3	$625K	Sell	29,000 -87,400	-75%	-$2.03M	﹤0.01%	1932
2018 Q2	$2.83M	Buy	116,400 +97,400	+513%	+$1.99M	0.01%	1372
2018 Q1	$324K	Buy	19,000 +15,000	+375%	+$293K	﹤0.01%	2154
2017 Q4	$76K	Buy	+4,000	New	+$60.2K	﹤0.01%	1997
2017 Q3	–	Sell	-2,000	Closed	-$66K	–	2332
2017 Q2	$66K	Hold	2,000	–	–	﹤0.01%	2143
2017 Q1	$66K	Buy	+2,000	New	+$68.3K	﹤0.01%	2078
2014 Q1	–	Sell	-50,000	Closed	-$2M	–	1799
2013 Q4	$2M	Hold	50,000	–	–	0.01%	1123
2013 Q3	$1.89M	Hold	50,000	–	–	0.01%	1111
2013 Q2	$1.96M	Buy	+50,000	New	+$1.95M	0.01%	932

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

HSBC Holdings's TEVA Position: Q2 2026 in Review

HSBC Holdings reduced its Teva Pharmaceutical Industries Limited (TEVA) stake by 18% in Q2 2026, selling an estimated $5.85M and leaving 785,524 shares worth $26.6M. The position accounts for 0.01% of the portfolio, ranked #680.

HSBC Holdings first reported a position in TEVA in Q2 2013 and has held it in 53 quarters since. The position peaked at $29.9M in Q3 2025. 676 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

HSBC Holdings held 785,524 shares of Teva Pharmaceutical Industries Limited worth $26.6M as of Q2 2026.
HSBC Holdings sold 175,616 Teva Pharmaceutical Industries Limited shares in Q2 2026, an estimated $5.85M.
Teva Pharmaceutical Industries Limited made up 0.01% of HSBC Holdings's portfolio in Q2 2026, its #680 holding.
HSBC Holdings first reported a position in Teva Pharmaceutical Industries Limited in Q2 2013 and has held it in 53 quarters since.
HSBC Holdings's Teva Pharmaceutical Industries Limited position peaked at $29.9M in Q3 2025.
676 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2026.

Based on HSBC Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.